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ABSTRACT
The aim of this study was to evaluate the effects of afl atoxin and glukomannan on some coagulation 
parameters. In the study, 40 New Zealand rabbits were used and the rabbits were separated equally into four 
groups as control (C), glucomannan (G), glucomannan + afl atoksin (AG) and afl atoxin (A). At the end of the (10 
week) experiment, APTT and PT values in group A were signifi cantly (P<0.05) shorter than those in the control 
group. Fibrinogen concentrations were higher in groups A and AG than in the control group, but there was no 
signifi cant difference between the groups. The thrombocyte count was signifi cantly (P<0.05) increased in group 
A compared with the other groups. In conclusion, in this study this afl atoxin dose did not cause coagulation 
disorders as seen by shortness in PT and APTT levels. This might be explained by the fact that this dose 
stimulated the coagulation mechanism due to the slight negatively effect which initiated coagulation response. 
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Introduction
One of the most important problem occurring as a result of unsuitable storage of food 
and foodstuff is toxication caused by mycotoxins produced by mould (ÇELIK et al., 2000a). 
Afl atoxins are the mostly seen mycotoxins. Afl atoxin B1, which is produced by Aspergillus 
fl avus and Aspergillus parasiticus, is the most harmful (ÇELIK et al., 1996; ERASLAN et al., 
2004; ABDEL-WAHAB et al., 2002). Susceptibility to the toxic effects of afl atoxin B1 varies 
between species. Rabbits are amongst most sensitive animal species (BAKER and GREEN, 
1987). Afl atoxicosis results in with anaemia (KEÇECI et al., 1998), inhibition of immune 
function (ÇELIK et al., 2000b), harmful effects in the liver and kidneys (JINDAL et al., 
1994), mutagenesis, teratogenesis, carcinogenesis and haemorrhages (ŞEHU et al., 2005).
Signifi cant changes in serum biochemical and haematological parameters are seen in 
afl atoxicosis cases and these can assist in the diagnosis of toxications (BASMACIOĞLU 
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et al., 2005). Clinical bleeding and abnormal coagulation have been noted in animals 
intoxicated by afl atoxin B1 both experimentally and naturally. KEÇECI et al. (1995) have 
reported that afl atoxicosis caused a decrease in haemoglobin, haematocrit values and 
thrombocyte counts in broilers. 
Removing AF from contaminated food and foodstuffs remains a major problem 
and there is a great demand for effective decontamination technology. Decontamination 
procedures have focused on degrading, destroying, inactivating or removing AF by 
physical, chemical or biological methods (OĞUZ et al., 2000). The benefi cial effects of 
Saccharomyces cerevisiae (SCE) have been attributed to mannan which is a cell wall 
component (DIAZ et al., 2002; RAJU and DEVEGOWDA, 2000). Esterifi ed glucomannan (EG) 
showed very high binding ability (80-97%) with AF (DIAZ et al., 2002; BASMACIOĞLU 
et al., 2005). The studies performed with EG at different concentrations of AF showed 
that EG partially or completely reversed the effect of AF on performance, biochemistry, 
haematology and immune response (RAJU and DEVEGOWDA, 2000; ARAVIND et al., 2003; 
SANTIN et al., 2003).
The aim of this study was to evaluate coagulation abnormality in rabbits intoxicated with 
afl atoxin to determine the counteraction of glucomannan application to afl atoxicosis.
Materials and methods
In the present study, 40 healthy New Zealand white rabbits were used. The rabbits 
were divided into 4 equal groups where the weight of each group of animals was close to 
each other. All the rabbits were kept in individual cages during the experiment (10 weeks) 
and were fed ad libitum as follows:
Group 1 (C); fed with pellet food
Group 2 (A); fed with pellet food containing 125 ppb afl atoxin
Group 3 (AG); fed with pellet food containing 1000 ppm glucomannan + 125 ppb 
afl atoxin
Group 4 (G); fed with pellet food containing 1000 ppm glucomannan
During the experiment animals had free access to water. 
At the end of the experiment;, blood samples were collected by cardiac puncture into 
citrated tubes to evaluate coagulation parameters. Thrombocyte counts were determined 
by haemocytometer. PT (prothrombin time), APTT (partial thromboplastin time) and 
fi brinogen determination was determined by commercial kits (DiaMed, DiaFibrinogen 
B305100; DiaCelin Liquid Cephaloplastin B301100; DiaMed, DiaPlastin B300240) 
using a coagulometer (DiaLab, Diaclot, C4Combi Coagulometer). 
Statistical differences among the groups were tested by Duncan’s multiple range test 
using SPSS for Windows, version 10.0. P<0.05 was considered signifi cant.
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Results
Comparison of some coagulation parameters of the control and treatment groups is 
shown in Table 1.
Table 1. Coagulation parameters in control and afl atoxin and glucomannan groups. 
Parameters C G AG A
Thrombocyte (×105/mm3) 402.40 ± 0,43c 405 ± 0.10c 417.66 ± 0.33b 488.6 ± 0.28a
PT (s) 9.45 ± 0.47a 7.91 ± 0.21b 7.33 ± 0.48bc 6.51 ± 0.25c
APTT (s) 19.20 ± 0.60a 17.70 ± 0.79ab 16.56 ± 1.30ab 15.80 ± 0.61b
Fibrinogen (mg/dL) 426.5 ± 39.32 431.8 ± 79.45 455.8 ± 49.25 550.0 ± 59.72
APTT: activated partial thromboplastin time; PT: prothrombin time; a, b, c: P<0.05.
Discussion
The liver plays an important role in haemostasis. Hepatocytes synthesize large 
numbers of coagulation factors. Assessment of coagulation status is important in animals 
suspected of having liver disease, because altered haemostasis can contribute to clinical 
signs and complicate invasive diagnostic procedures. The commonly used tests to assess 
coagulation status include determination of prothromin time (PT), activated partial 
thromboplastin (APTT) and fi brinogen (ÇAM et al., 2006). For this reason the effects of 
afl atoxin which has mitogenic, hepatotoxic, hepatocarsinogenic and immunosupressif 
effects (ÇELIK et al., 2000a), were used to determine some coagulation parameters in 
rabbits.
CLARK et al. (1986) reported that the coagulation defect in rabbits given AFB1 was 
characterized by prolonged PTs and APTTs and decreased activity of fi brinogen and 
increased platelet numbers. Additionally OSUNA and EDDS (1982) found signifi cantly 
increased PT and APTT in pigs fed afl atoxin. Also in another study, afl atoxicosis decreased 
factors V, VII and VIII activity, fi brinogen concentration, platelet number and detectable 
plasma fi brin monomers (BAKER and GREEN, 1987). ESPADA et al. (1997) reported that 
mycotoxicosis increased fi brinogen concentration and decreased PT values in broilers. 
Additionally some researchers have found decreased thrombocyte count in afl atoxin 
treatment groups (KEÇECI et al., 1998; OĞUZ et al., 2000; BASMACIOĞLU et al., 2005). 
In the present study, APTT and PT values in group A were signifi cantly (P<0.05) 
shorter than those in the control group. Moreover, fi brinogen concentrations were higher 
in groups A and AG than in the control group, but there was no signifi cant difference 
between the groups. The thrombocyte count was also signifi cantly (P<0.05) increased in 
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group A compared with the other groups. The decreased PT and APTT values observed 
may be consistent with increased plasma fi brinogen concentration. At the same time the 
increase in thrombocyte and fi brinogen levels may demonstrate a regenerative response 
with a haemarogical tendency. These fi ndings agreed with the above reports that explain 
the suppressive effects of AF on coagulation. Single additions of glucomannan to AF 
- free diets did not produce any negative changes compared to the control. This also 
supported the notion that glucomannan was inert and non-toxic in terms of coagulation 
parameters. Our results showed the benefi cial effects of glucomannan in the detoxifi cation 
of AF. The levels of the AG group close to the other groups showed the benefi cial effects 
of glucomannan on afl atoxin. 
In conclusion, although the coagulation defects of afl atoxicosis are primarily due to 
the diminished hepatic synthesis of coagulation and initiating intravascular coagulation 
and consumption of coagulation factors (BAKER and GREEN, 1987), in this study this 
afl atoxin dose did not cause coagulation disorders as seen in shortness in PT and APTT 
levels. This might be explained by the fact that this dose stimulated the coagulation 
mechanism due to a slight negative effect which initiates the coagulation response. 
_______
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SAŽETAK
Cilj istraživanja bio je procijeniti učinke afl atoksina i glukomanana na neke pokazatelje grušanja. 
Istraživanje je provedeno na 40 novozelandskih kunića podijeljenih u četiri jednake skupine: kontrolnu skupinu, 
skupinu koja je dobivala glukomanan, skupinu koja je dobivala istodobno afl atoksin i glukomanan te skupinu 
koja je dobivala samo afl atoksin. Na kraju pokusa koji je trajao 10 tjedana aktivirano parcijalno tromboplastinsko 
vrijeme (APTT) i protrombinsko vrijeme (PT) bilo je značajno kraće (P<0,05) u skupini koja je dobivala 
afl atoksin nego u životinja kontrolne skupine. Koncentracije fi brinogena bile su veće u kunića skupine koja je 
dobivala afl atoksin i skupine koja je dobivala istodobno afl atoksin i glukomanan nego u kontrolne skupine, ali 
nije bila ustanovljena statistički značajna razlika između skupina. Broj trombocita bio je značajno (P<0,05) veći 
u kunića skupine koja je dobivala afl atoksin u usporedbi s drugim skupinama. Zaključuje se da davane doze 
afl atoksina nisu uzrokovale poremećaje grušanja kako se vidi iz PT i APTT. To se može objasniti time da je 
davana doza potaknula mehanizam grušanja zbog blagoga negativnoga učinka koji je bio začetnik grušanja.
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